Nate Crossett

Stock Analyst at Exane BNP Paribas

(1.95)
# 3,193
Out of 5,090 analysts
38
Total ratings
50%
Success rate
1.56%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Mar 12, 2025
Upgrades: Outperform
Price Target: $5$9
Current: $5.48
Upside: +64.23%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $45.73
Upside: -34.40%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $73.90
Upside: -13.40%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $17.46
Upside: -2.63%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $58.48
Upside: +7.73%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $45.48
Upside: +137.47%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $80.61
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $164.73
Upside: -16.23%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $127.98
Upside: +10.17%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $41.89
Upside: +50.39%
Initiates: Underperform
Price Target: $42
Current: $40.21
Upside: +4.45%
Initiates: Outperform
Price Target: $41
Current: $27.73
Upside: +47.85%
Initiates: Outperform
Price Target: $29
Current: $30.65
Upside: -5.38%
Initiates: Underperform
Price Target: $74
Current: $66.31
Upside: +11.60%
Initiates: Outperform
Price Target: n/a
Current: $13.45
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $8.11
Upside: +18.37%
Initiates: Outperform
Price Target: $66
Current: $84.31
Upside: -21.72%
Initiates: Outperform
Price Target: $38
Current: $10.75
Upside: +253.49%
Initiates: Outperform
Price Target: $886
Current: $741.58
Upside: +19.47%
Downgrades: Hold
Price Target: $31$30
Current: $23.08
Upside: +29.98%
Initiates: Buy
Price Target: $21
Current: $9.36
Upside: +124.36%
Downgrades: Hold
Price Target: $21$25
Current: $9.13
Upside: +173.82%
Upgrades: Buy
Price Target: n/a
Current: $35.21
Upside: -